Professor Mark Garton
Consultant Physician and Rheumatologist
MD, FRCP(Edin), FRCP(London), MSc
I have broad experience in general medicine and rheumatology, and have a special interest in metabolic bone disease.
As a Consultant in Scotland and England, I have been involved in establishing and modernising bone density screening services, and have personally reported about 20,000 DXA scans since 2010. Over the last decade the greater part of my private and NHS practice has been focused on advising patients on how best to prevent and treat osteoporosis, taking account of personal preferences and the potential risks and benefits of drug interventions.
I studied at St George's Hospital Medical School in London, and qualified in 1985. Higher medical training followed in Scotland, including two years as a Wolfson Research Fellow attached to the Health Services Research Unit, University of Aberdeen. This provided ample research opportunities to complete my MD on strategies for the prevention of osteoporosis (1996), and a Masters in Public Health (1993).
Some of the principal treatments carried out by Professor Mark Garton at Spire include:
COVID-19 testing or antibody tests are not available as a standalone service at Spire Yale Hospital.
MB BS / University of London / 1985
Bachelor of Medicine Bachelor of Surgery
MB BS is a degree given to physicians on completion of basic training.
MSc Public Health / University of Aberdeen / 1993
Master of Science (Public Health)
MSc is an optional degree in a more specialised area.
MD / University of London / 1996
Doctor of Medicine
MD is a higher professional degree
British Society for Rheumatology
I have participated in NHS research studies related to prevention of Paget's disease, and more recently into mitigation of the more severe effects of Covid 19 infection using a range of anti-inflammatory medications such as steroids and cytokine blockers. I have an interest also in studying similar interventions in patients with rheumatoid arthritis associated lung disease.
Garton M, McInnes IB, Sattar N. Comment on:Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis Rheumatology (Oxford). 2020 Feb 1;59(2):453-454. doi: 10.1093/rheumatology/kez613.
Garton M. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates (Letter). NEJM 2020; 383: 2189
Recovery collaborative group. Effect of hydroxychloroquine in hospitalised patients with Covid-19. NEJM 2020; 383: 2030-40
Medical Informatics Officer, Wrexham Maelor Hospital; Visiting Professor Wrexham Glyndwr University.
I am married to Clare (an occupational therapist) and have two daughters, one of whom is still at school. We moved from Perthshire to Shropshire in 2010, for work reasons, and have made many new friends here. However, we still have family in Scotland and return every year to visit them. We all enjoy walking in the countryside, but do not miss the harsh Scottish winters.
Music has been a large part of our lives for many years, and my wife and I have actively supported both the Oswestry School Recital Series and the Whittington International Music Festival. I have played the cello for over 40 years and perform in small chamber groups and a local orchestra, organising three charity concerts at the Robert Jones and Agnes Hunt Orthopaedic Hospital since 2012.